Next |
home / stock / itci / itci message board
Subject | By | Source | When |
---|---|---|---|
Geez..... No posting on this stock for over | Chrisny73 | investorshub | 12/22/2021 9:28:10 PM |
$ITCI > diluting > shelf placement last Friday! | crudeoil24 | investorshub | 09/14/2020 5:32:46 PM |
$ITCI respecting the ma20 on the 240min chart ~ | $treet $inatra | investorshub | 09/14/2020 5:27:21 PM |
znewcar1: ITCI 72% v43,9M c31.86 f67,3M gap up preMH42.99 S28.5 | znewcar1 | investorshangout | 09/09/2020 9:09:29 PM |
* * $ITCI Video Chart 09-09-2020 * * | ClayTrader | investorshub | 09/09/2020 8:37:57 PM |
Stock Analyzer | swingingRichard | investorshub | 04/22/2020 7:58:38 PM |
Wow, $38 in December 2019 and now after | gi197845 | investorshub | 03/16/2020 1:41:09 AM |
How is the underwriting going? | runner16 | investorshub | 01/24/2020 3:28:51 PM |
znewcar1: ITCI | znewcar1 | investorshangout | 01/13/2020 2:36:25 AM |
maybe your right | TheFinalCD | investorshub | 01/07/2020 4:55:47 AM |
If that's the case, then maybe you should | gi197845 | investorshub | 01/07/2020 3:00:34 AM |
lol. | Milo1 | investorshub | 01/07/2020 1:23:04 AM |
thats because I am not in, let me | TheFinalCD | investorshub | 01/06/2020 10:58:01 PM |
I found that interesting as well. PPS has | Milo1 | investorshub | 01/06/2020 10:55:21 PM |
huh? and no significant price movement | TheFinalCD | investorshub | 01/06/2020 10:46:30 PM |
$ITCI 10M share offering. | Milo1 | investorshub | 01/06/2020 9:29:47 PM |
It's interesting to note that ticker $ACAD, Acadia | gi197845 | investorshub | 12/30/2019 2:26:38 PM |
so immature, and misleading, this is not elementary | TheFinalCD | investorshub | 12/26/2019 12:46:34 PM |
* * $ITCI Video Chart 12-24-2019 * * | ClayTrader | investorshub | 12/24/2019 6:48:42 PM |
Carl Icahn took stake today | Biggeoff | investorshub | 12/24/2019 4:33:20 PM |
News, Short Squeeze, Breakout and More Instantly...
Intra-Cellular Therapies Inc. Company Name:
ITCI Stock Symbol:
NASDAQ Market:
Intra-Cellular Therapies Inc. Website:
CAPLYTA Q1 2024 net product sales were $144.8 million , compared to $94.7 million for the same period in 2023 , representing a 53% increase CAPLYTA’s strong prescription uptake continues: Q1 2024 CAPLYTA total prescripti...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...
NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the developme...